Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
BridgeBio Pharma announced the pricing of a secondary offering of 5 million shares of common stock by selling shareholder KKR Genetic Disorder L.P. The company itself is not selling shares and will not receive proceeds from this transaction. The offering aims to diversify and evolve BridgeBio's institutional shareholder base toward long-term, high-…
Wrap Technologies has been chosen by WOFT Charities to provide training services for a newly funded $475,000 Teacher Safety Training Program in Florida. This program aims to enhance situational awareness and safety skills among teachers and school personnel, expanding Wrap’s public safety training expertise beyond law enforcement into education.
Super League Enterprise, Inc. announced second quarter 2026 financial results showing sequential net revenue growth of 16%, gross margin expansion to 41%, and a 20% year-over-year improvement in adjusted EBITDA, despite flat gross revenue in a tough advertising environment. The company successfully integrated Misfits Ads assets without raising cost…
Beneficient, a Nasdaq-listed technology-enabled platform for alternative asset liquidity and capital solutions, reported its Q1 FY 2027 results showing progress in strategic initiatives. Key developments include securing its first collateral management services agreement with a Texas state-chartered bank, generating expected recurring fee revenue, …
Diginex Limited announced an extraordinary general meeting scheduled for October 8, 2026, seeking shareholder approval for its proposed acquisition of Resulticks Global Companies. The acquisition consideration involves issuing 600 million new shares of Diginex at $1.75 per share. Additionally, Diginex plans to increase authorized share capital and …
Edible Garden AG Incorporated reported a 12.8% increase in revenue to $3.6 million and a 31.2% increase in total sales for Q2 2026, driven by strong growth in fresh-cut herbs, condiments, and international vitamins. The company expanded retail partnerships, including new distribution agreements with Target, Kroger, and Weis Markets, and progressed …
Milestone Scientific Inc. reported a 22% year-over-year revenue increase for Q2 2026 to $2.8 million, driven by a 231% surge in medical segment sales, particularly CompuFlo®. The company reaffirmed a 2026 outlook of double-digit revenue growth, highlighting strategic distribution agreements expanding access to federal healthcare systems and Medicar…
Helus Pharma reported Q1 Fiscal 2027 results highlighting completion of enrollment in its Phase 3 APPROACH study for HLP003 in Major Depressive Disorder with top-line data expected in Q4 2026. The company appointed Michael Halstead as CEO to lead late-stage development and commercialization efforts. Its Phase 2 candidate HLP004 showed meaningful im…
Wetour Robotics shares spiked sharply in pre-market trading after the company disclosed a new Regulation S private placement and scheduled an Extraordinary General Meeting to vote on another reverse split and a larger authorized share count. The move highlights a classic micro-cap, event-driven setup: renewed liquidity, a near-term binary corporate…
Outlook Therapeutics announced its Q3 fiscal 2026 financial results and detailed progress toward the U.S. commercial launch of LYTENAVA™, the only FDA-approved ophthalmic bevacizumab for wet age-related macular degeneration (wet AMD). The company aims to launch LYTENAVA in the U.S. by the end of 2026 and projects potential annual sales exceeding $5…
Oil climbed on Friday and was positioned to record weekly gains after U.S. officials said a naval blockade of Iran could be maintained indefinitely, stoking concerns about disruptions to Middle East supplies. Brent and U.S. crude rose modestly while traffic through the Strait of Hormuz fell below the month's average. At the same time, forecasts fro…
PowerCompute, a Nasdaq-listed Bitcoin mining and treasury company, reported Q2 2026 revenue growth of 9.8% year-over-year driven by increased Bitcoin mining production despite lower Bitcoin prices. The company expanded strategically into high-performance computing (HPC) and AI infrastructure leveraging its power assets and entered into a GPU comput…
Quantum BioPharma Ltd. reported a stronger liquidity position with cash and equivalents nearly doubling to $3.65 million and total assets increasing to $9.5 million as of mid-2026. The company reduced operating expenses by over 50% year-over-year while extending its cash runway to at least October 2027. Importantly, the FDA approved Quantum's Inves…
Aurora Mobile Limited (NASDAQ: JG) announced a three-year Memorandum of Understanding with Exabytes, a leading AI-driven digital solutions provider in Southeast Asia, to jointly develop and deploy AI-powered customer engagement solutions. The partnership aims to integrate Aurora Mobile’s AI-first platforms, EngageLab and GPTBots.ai, with Exabytes’ …
Fate Therapeutics has initiated the RECLAIM-LN Phase 2 clinical trial of its off-the-shelf FT819 CAR T-cell therapy in patients with refractory moderate-to-severe systemic lupus erythematosus (SLE) with lupus nephritis. The trial, supported by RMAT designation and FDA pilot programs, aims to enroll about 53 patients and evaluate the therapy's safet…
Adlai Nortye Ltd. reported strong operational progress with ongoing enrollment in global Phase I trials for its pan-RAS(ON) inhibitor AN9025 and regulatory approval for Phase I trial of AN4035 ADC. The company raised a total of $290 million in equity financing in early 2026, significantly boosting its cash reserves. Financial results show increased…
Teamshares announced Q2 2026 results showing 20% revenue growth to $148.7 million, net income of $9.5 million, and a 166% increase in Adjusted EBITDA year-over-year. The company reaffirmed its 2026 full-year outlook with a $40 million EBITDA acquisition target, underpinned by a strong pipeline including $30 million annual EBITDA under letters of in…
Neumora Therapeutics reported its second quarter 2026 financial results, highlighting progress in its drug pipeline including favorable preclinical data for NMRA-215 with planned IND submission and Phase 1 study initiation by end of 2026. NMRA-511 and NMRA-898 programs targeting Alzheimer's agitation and schizophrenia are progressing towards clinic…
Tvardi Therapeutics announced its second quarter 2026 financial results and provided a business update highlighting topline healthy volunteer results for its next-generation STAT3 inhibitor, TTI-109, confirming the prodrug design, improved tolerability, and reductions in immune cell populations relevant to ulcerative colitis (UC). The company selec…
Beyond Meat, Inc. has completed a 1-for-30 reverse stock split effective August 13, 2026, reducing the number of outstanding shares and authorized shares to help the company meet Nasdaq's minimum bid price requirement. The adjusted shares will begin trading on August 14, 2026 under the ticker BYND. The reverse split proportionately adjusts conversi…
JOYY Inc., a global technology company listed on NASDAQ, announced it will release its second quarter 2026 financial results after U.S. market close on August 25, 2026. The company's management will host an earnings conference call to discuss the results on the same day, providing a webcast and replay access for investors and analysts.
Citi says the environment for gold is turning more favourable as U.S. front-end yields roll over and exchange-traded fund flows have increased since mid-July. Nevertheless, the bank is refraining from adding exposure after a swift run-up in prices and is waiting for consolidation. Citi also notes that gold remains near its short-term strategists' t…
IperionX ($IPX) is executing on a clear strategy: convert domestic titanium scrap into low-carbon titanium powders, lock up feedstock, and run customer qualification programs that can underpin premium pricing and long-term offtakes. Recent steps - most notably the June acquisition of adjacent Camden assets for $3.0M - materially reduce feedstock ri…
Brookfield Business Corporation has announced the renewal of its normal course issuer bid, authorizing the company to repurchase up to 10,272,100 Class A subordinate voting shares, representing 5% of outstanding shares. The buyback, effective from August 19, 2026, to August 18, 2027, aims to invest in shares that trade below their perceived intrins…
Rein Therapeutics reported strong progress in its Phase 2 RENEW trial of LTI-03 for idiopathic pulmonary fibrosis (IPF), surpassing 25% enrollment ahead of schedule and expecting interim data in H2 2026. The company also completed an oversubscribed $57.5 million public offering, strengthening its financial position to fund ongoing operations throug…
